- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interstitial lung disease associated with systemic sclerosis (SSc-ILD) ; volume:20 ; number:1 ; day:18 ; month:1 ; year:2019 ; pages:1-10 ; date:12.2019
Respiratory research ; 20, Heft 1 (18.1.2019), 1-10, 12.2019
- Creator
-
Cottin, Vincent
Brown, Kevin K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-0980-7
- URN
-
urn:nbn:de:101:1-2019022022080056189134
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cottin, Vincent
- Brown, Kevin K.
- SpringerLink (Online service)
Other Objects (12)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Pathogenesis of interstitial lung disease in systemic sclerosis
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Pathogenesis of interstitial lung disease in systemic sclerosis
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Pathogenesis of interstitial lung disease in systemic sclerosis
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases